Assessment of cardiovascular risk and choice of antihypertensive therapy

Area of Science:

• Cardiology
• Internal Medicine
• Public Health

Background:

• Hypertension management requires individualized therapy based on cardiovascular risk.
• Elevated blood pressure often coexists with other risk factors, influencing treatment decisions.
• The impact of hypertension is incremental, affecting even high-normal blood pressure ranges.

Purpose of the Study:

• To emphasize the link between hypertension treatment and multivariate cardiovascular risk.
• To guide the selection of antihypertensive agents based on patient-specific risk factors and vascular conditions.
• To highlight the importance of rigorous blood pressure control.

Main Methods:

• Review of current hypertension guidelines and risk assessment strategies.
• Analysis of the interplay between hypertension, cardiovascular disease risk factors, and metabolic syndrome.
• Evaluation of treatment indications for prehypertension and established hypertension.

Main Results:

• Treatment choices for hypertension should be integrated with multivariate cardiovascular risk assessment.
• Associated risk factors significantly modify the clinical impact of elevated blood pressure.
• Specific antihypertensive agents may be more efficacious in patients with particular risk factors or vascular conditions.

Conclusions:

• Rigorous blood pressure control is paramount in hypertension management.
• Prehypertension may warrant drug treatment if multivariate risk or target-organ damage is present.
• Patients with metabolic syndrome require comprehensive management including lifestyle changes and tailored antihypertensive therapy.